| |
| |
|
| Insider
Information: |
Moyes Jay M |
| Relationship: |
Chief Financial Officer |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
240,313 |
|
|
Indirect Shares
|
165,659 |
|
|
| Direct
Value |
$1,458,565 |
|
|
|
Indirect Value
|
$9,080 |
|
|
| Total
Shares |
405,972 |
|
|
| Total
Value |
$1,467,645 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -45.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Myriad Genetics Inc |
MYGN |
Chief Financial Officer |
2007-10-15 |
25,282 |
2007-09-13 |
400 |
Premium* |
|
|
Osiris Therapeutics, Inc. |
OSIR |
Director |
2013-02-12 |
21,500 |
2007-02-05 |
0 |
Premium* |
|
|
Sintx Technologies Ord Shs |
SINT |
Chief Financial Office... |
2014-02-19 |
60,312 |
2014-02-19 |
6,250 |
Premium* |
|
|
Tiger X Medical Inc |
CDOM |
Director |
2021-03-31 |
54,267 |
2016-10-24 |
159,009 |
Premium* |
|
|
Puma Biotechnology Inc |
PBYI |
Director |
2023-06-13 |
43,322 |
2018-06-12 |
0 |
Premium* |
|
|
Sera Prognostics, Inc. |
SERA |
Chief Financial Officer |
2023-03-06 |
35,630 |
2021-07-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MYGN |
Myriad Genetics Inc |
V.P. Finance & C.F.O. |
• – – |
2005-06-09 |
4 |
OE |
$3.50 |
$19,250 |
D/D |
5,500 |
15,738 |
|
- |
|
| MYGN |
Myriad Genetics Inc |
officerTitle |
• – – |
2005-12-21 |
4 |
AS |
$19.96 |
$48,913 |
D/D |
(2,448) |
14,456 |
|
- |
|
| OSIR |
Osiris Therapeutics, Inc. |
Director |
– • – |
2007-02-05 |
4 |
OE |
$23.62 |
$35,430 |
D/D |
1,500 |
1,500 |
0 |
- |
|
| OSIR |
Osiris Therapeutics, Inc. |
Director |
– • – |
2008-02-04 |
4 |
A |
$12.01 |
$36,030 |
D/D |
3,000 |
4,500 |
0 |
- |
|
| OSIR |
Osiris Therapeutics, Inc. |
Director |
– • – |
2009-02-23 |
4 |
A |
$18.60 |
$55,800 |
D/D |
3,000 |
7,500 |
0 |
- |
|
| OSIR |
Osiris Therapeutics, Inc. |
Director |
– • – |
2010-05-27 |
4 |
A |
$6.46 |
$19,380 |
D/D |
3,000 |
10,500 |
0 |
- |
|
| OSIR |
Osiris Therapeutics, Inc. |
Director |
– • – |
2011-02-14 |
4 |
A |
$7.13 |
$21,390 |
D/D |
3,000 |
13,500 |
0 |
- |
|
| OSIR |
Osiris Therapeutics, Inc. |
Director |
– • – |
2012-03-23 |
4 |
A |
$5.08 |
$15,240 |
D/D |
3,000 |
16,500 |
0 |
- |
|
| OSIR |
Osiris Therapeutics, Inc. |
Director |
– • – |
2013-02-06 |
4 |
A |
$14.93 |
$74,650 |
D/D |
5,000 |
26,500 |
0 |
- |
|
| OSIR |
Osiris Therapeutics, Inc. |
Director |
– • – |
2013-02-12 |
4 |
A |
$7.73 |
$38,650 |
D/D |
5,000 |
21,500 |
0 |
- |
|
| CDOM |
Tiger X Medical Inc |
Director |
– • – |
2016-10-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
159,009 |
|
- |
|
| PBYI |
Puma Biotechnology Inc |
Director |
– • – |
2018-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
5,822 |
5,822 |
0 |
- |
|
| PBYI |
Puma Biotechnology Inc |
Director |
– • – |
2019-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
19,423 |
25,245 |
0 |
- |
|
| CDOM |
Tiger X Medical Inc |
Director |
• • – |
2019-07-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,594 |
3,961 |
0 |
- |
|
| CDOM |
Tiger X Medical Inc |
Director |
• • – |
2020-04-30 |
4 |
A |
$0.00 |
$0 |
D/D |
24,000 |
27,961 |
0 |
- |
|
| CDOM |
Tiger X Medical Inc |
Director |
• • – |
2020-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
8,800 |
36,761 |
0 |
- |
|
| PBYI |
Puma Biotechnology Inc |
Director |
– • – |
2020-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
25,748 |
50,993 |
0 |
- |
|
| PBYI |
Puma Biotechnology Inc |
Director |
– • – |
2020-06-16 |
4 |
S |
$9.50 |
$92,340 |
D/D |
(9,720) |
41,273 |
0 |
% |
|
| CDOM |
Tiger X Medical Inc |
Director |
• • – |
2020-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
3,750 |
40,511 |
0 |
- |
|
| PBYI |
Puma Biotechnology Inc |
Director |
– • – |
2020-09-16 |
4 |
S |
$10.00 |
$97,030 |
D/D |
(9,703) |
31,570 |
0 |
% |
|
| CDOM |
Tiger X Medical Inc |
Director |
• • – |
2020-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
3,750 |
44,261 |
0 |
- |
|
| CDOM |
Tiger X Medical Inc |
Director |
• • – |
2020-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
6,550 |
50,811 |
0 |
- |
|
| CDOM |
Tiger X Medical Inc |
Director |
• • – |
2021-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
3,456 |
54,267 |
0 |
- |
|
| PBYI |
Puma Biotechnology Inc |
Director |
– • – |
2021-06-10 |
4 |
S |
$11.36 |
$286,860 |
D/D |
(25,248) |
6,322 |
0 |
% |
|
| PBYI |
Puma Biotechnology Inc |
Director |
– • – |
2021-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
27,858 |
34,180 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
